Compare STOK & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | KSS |
|---|---|---|
| Founded | 2014 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2019 | 1995 |
| Metric | STOK | KSS |
|---|---|---|
| Price | $36.13 | $16.31 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 10 | 14 |
| Target Price | ★ $36.10 | $15.83 |
| AVG Volume (30 Days) | 560.9K | ★ 3.1M |
| Earning Date | 04-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.87% |
| EPS Growth | ★ 30.67 | N/A |
| EPS | 0.85 | ★ 1.30 |
| Revenue | ★ $36,555,000.00 | N/A |
| Revenue This Year | $430.19 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $42.08 | ★ $13.40 |
| Revenue Growth | ★ 316.34 | N/A |
| 52 Week Low | $5.35 | $6.04 |
| 52 Week High | $38.62 | $25.22 |
| Indicator | STOK | KSS |
|---|---|---|
| Relative Strength Index (RSI) | 64.73 | 35.02 |
| Support Level | $30.50 | $14.88 |
| Resistance Level | $37.98 | $17.04 |
| Average True Range (ATR) | 2.04 | 1.06 |
| MACD | 0.41 | -0.15 |
| Stochastic Oscillator | 77.87 | 3.17 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.